Exploring patient participation in reducing health-care-related safety risks

More documents

Recommendations

Info

Exploring patient participation in reducing health-care-related safety risks 158 Box A3 .2 . Categories of reactions Categories of reactions FNHTR Increase of body temperature of >=2°C (with or without rigors) during or in the first two hours after a blood transfusion, if no other cause for the fever can be found and haemolysis has been excluded. Exclusion of bacteriological or blood group serological causes and TRALI. Acute haemolytic transfusion reaction Signs starting within minutes or up to 24 hours after commencing transfusion, due to (usually complementmediated intravascular) destruction of red blood cells. Most often caused by transfusion of AB0-incompatible blood components, sometimes by irregular erythrocyte antibodies or occasionally by transfusion of a haemolytic red blood cell concentrate or infusion of hypotonic fluids. Delayed haemolytic transfusion reaction Immune-mediated destruction of red blood cells occurring >24 hours after, and as a result of, transfusion of a blood component. TRALI Clinical picture of adult respiratory distress syndrome: dyspnoea, hypoxia and a finely mottled appearance on chest X-ray with onset up to six hours after administration of a (plasma-containing) blood component, if other causes, such as anaphylaxis, infection and circulatory overload, have been excluded. Circulatory overload Onset within a few hours of transfusion of dyspnoea, orthopnoea, cyanosis, oedema of dependent parts, raised central venous pressure, with congestive picture on chest X-ray. Anaphylactic reaction Serious allergic reaction with onset within seconds to minutes of commencing transfusion, with signs such as airway obstruction, circulatory collapse or gastrointestinal signs as well as minor allergic manifestations. Other allergic reactions Within minutes to hours of starting transfusion, occurrence of allergic signs such as itching, erythema and urticaria, without serious allergic manifestations. Post-transfusion purpura Severe temporary thrombocytopenia arising roughly 9 (1–24) days after a transfusion of red blood cells and/or platelets, usually in a patient who has previously had a blood transfusion or been pregnant. Bacterial contamination Bacterial septicaemia that can be traced to a transfused blood component. May be difficult to distinguish from a haemolytic transfusion reaction. Confirm diagnosis by bacteriological culture on the patient and the blood component and/or another blood component resulting from the same donation. Viral infection Any viral infection that can be traced to a transfused blood component (hepatitis A, HBV, HCV, non-ABC, HIV, human T-cell lymphotropic virus, Epstein-Barr virus, cytomegalovirus etc.) Post-transfusion hepatitis Significant rise in transaminases between 14 and 180 days after transfusion or a serologically confirmed new infection with HBV or HCV in a patient who has been transfused. Transfusion-associated cytomegalovirus infection A (probably) – primary cytomegalovirus infection in a recipient of a blood component should be reported. Transfusion-associated graft-versus-host disease reaction Reaction 1–6 weeks (usually 8–10 days) after a T-cell blood component is administered, with (initially central) erythema, watery diarrhoea, elevated liver enzymes and pancytopenia – generally involving a high risk of mortality and caused by an immunological reaction of the donor’s T lymphocytes to the tissues of the recipient (who had suppressed immunity).
Box A3 .2 . contd Haemosiderosis Haemosiderosis in a multiple-transfused patient. Patient involvement in blood transfusion in the Netherlands Development of new antibody against blood cell antigen Detection, after a transfusion, of a clinically relevant antibody (irregular erythrocyte antibody, human leukocyte antigen antibody or human platelet antigen antibody) against a blood cell antigen where that antibody had never previously been detected (to the extent of the hospital’s knowledge). Other transfusion reactions » Rigors without fever » Post-transfusion malaria » Other parasitic infections in a transfusion recipient » Transfusion refractoriness Mild febrile reaction (optional reporting by sentinel hospitals) Rise in body temperature of >1
Page 1 and 2:
Exploring patient participation in
Page 3 and 4:
ABSTRACT Patients’ rights have be
Page 5 and 6:
iv Patient information: the link be
Page 7 and 8:
vi LIST OF TABLES, FIGURES AND BOXE
Page 9 and 10:
ACKNOWLEDGEMENTS The editors would
Page 11 and 12:
LIST OF ABBREVIATIONS ABHR alcohol-
Page 13 and 14:
FOREWORD Health is a social value a
Page 15 and 16:
ChApTER 1. pATIENTS’ RIGhTS AND p
Page 17 and 18:
Box 1 .1 . contd Reporting and Lear
Page 19 and 20:
The causal mechanisms through which
Page 21 and 22:
» be involved in routine monitorin
Page 23 and 24:
elationships within the complex env
Page 25 and 26:
ChApTER 2. pATIENTS’ RIGhTS AND p
Page 27 and 28:
CoE Recommendation 2006/7 of the Co
Page 29 and 30:
The 2005 United States act on patie
Page 31 and 32:
The right to participate in policy-
Page 33 and 34:
The right to participate in quality
Page 35 and 36:
» engaging with patient representa
Page 37 and 38:
hampered by the written and spoken
Page 39 and 40:
prevents misunderstandings and shap
Page 41 and 42:
Health care providers should nevert
Page 43 and 44:
Recommendation 7 - Encourage the av
Page 45 and 46:
20. Constitution of the World Healt
Page 47 and 48:
ChApTER 3. pATIENT pARTICIpATION IN
Page 49 and 50:
awareness of the sociomedical burde
Page 51 and 52:
Patient participation in hand hygie
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Blood transfusion safety in France:
Page 63 and 64:
Page 65 and 66:
Box 4 .1 . Definitions of adverse e
Page 67 and 68:
Fig . 4 .4 . Distribution of advers
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
The heterogeneity of situations and
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Fig . 4 .12 . Patients’ response
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Patient safety, rights and medicati
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Fig . 5 .3 . Frequency with which d
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
ChApTER 6. pATIENT pARTICIpATION IN
Page 109 and 110:
Patient participation in elective s
Page 111 and 112:
e desirable to have a special statu
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
inspections of surgical services to
Page 119 and 120:
Page 121 and 122: Patient participation in elective s
Page 133 and 134: » being involved in monitoring and
Page 135 and 136: Other studies on patient attitudes
Page 137 and 138: Information about patients’ exper
Page 139 and 140: available evidence suggests that in
Page 141 and 142: Adverse events Respondents from the
Page 143 and 144: Feeling safe Five per cent of hospi
Page 145 and 146: probability proportional to populat
Page 147 and 148: care professionals’ and patients
Page 149 and 150: group recommends that patient invol
Page 151 and 152: 13. Hibbard JH et al. Can patients
Page 153 and 154: 52. Triemstra M et al. Measuring cl
Page 155 and 156: 2009 (http://www.bradfordresearch.n
Page 157 and 158: of a small-scale patient survey add
Page 159 and 160: Box 8 .2 . Curricula and CME Chapte
Page 161 and 162: is provided through interaction of
Page 163 and 164: Box 8 .4 . Patient education Chapte
Page 165 and 166: ANNEX 1. QUOTATIONS FROM INTERNATIO
Page 167 and 168: (2) When designing adverse event re
Page 169 and 170: 17) If yes, do you think this was m
Page 171: Box A3 .1 . Reporting procedure Pat
Page 175 and 176: ANNEX 4. pATIENT QUESTIONNAIRE ABOU
Page 177 and 178: ANNEX 6. WhO pATIENT SAFETY pROGRAM
Page 179 and 180: especially those in intensive care.
Page 181 and 182: ANNEX 7. hANDOVER pROjECT Paul Bara
Page 183 and 184: (a) Provide new insight into the ro
Page 185 and 186: Johnson J, Barach P. Handovers of p
Page 187 and 188: Enhancing the patients’ role in p
Page 189 and 190: Enhancing the patients’ role in p
show all

Exploring patient participation in reducing health-care-related safety risks

Create successful ePaper yourself

Delete template?

Save as template?